Chemical Structure : NMS-P715
CAS No.: 1202055-32-0
Catalog No.: PC-43014Not For Human Use, Lab Use Only.
NMS-P715 is a potent, selective, orally bioavailable Mps1 inhibitor with IC50 of 8 nM, Ki of 0.99 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $118 | In stock | |
10 mg | $188 | In stock | |
25 mg | $328 | In stock | |
50 mg | $528 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NMS-P715 is a potent, selective, orally bioavailable Mps1 inhibitor with IC50 of 8 nM, Ki of 0.99 nM.
NMS-P715 displays excellent selectivity in vitro against a panel of 60 kinases at 5 uM.
NMS-P715 selectively reduces cancer cell proliferation, leaving normal cells almost unaffected, promotes massive spindle assembly checkpoint (SAC) in U2OS cells with EC50 of 68 nM.
NMS-P715 causes a reduction in G1 phase and a flattening in G2/M phase of the cell cycle accompanied by histone H3 dephosphorylation, PARP cleavage, and histone H2AX phosphorylation.
NMS-P715 inhibits tumor growth in preclinical cancer models.
M.Wt | 676.7311 | |
Formula | C35H39F3N8O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: < 6.9 mg/mL |
|
Chemical Name/SMILES |
1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, N-(2,6-diethylphenyl)-4,5-dihydro-1-methyl-8-[[4-[[(1-methyl-4-piperidinyl)amino]carbonyl]-2-(trifluoromethoxy)phenyl]amino]- |
1. Colombo R, et al. Cancer Res. 2010 Dec 15;70(24):10255-64.
2. Slee RB, et al. Mol Cancer Ther. 2014 Feb;13(2):307-315.
3. Maachani UB, et al. Mol Cancer Res. 2015 May;13(5):852-62.
4. Gurden MD, et al. Cancer Res. 2015 Aug 15;75(16):3340-54.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright